Find us at the World Health Summit in Berlin, October 11–13. Attending? Get in touch →
All-terrain advisors for global health.
Avenir is a strategic advisory firm for mission-driven leaders in health and life sciences making high-stakes decisions. Negotiation is our discipline: preparing for the moments that decide outcomes, and structuring the agreements that follow.
WHO WE WORK WITH
We work across global health and life sciences.
Builders.
Founders in life sciences, healthcare, and global health.
Before a raise, a first major partnership, or a new market.
Backers.
Foundations, impact investors, family offices, other funders.
When a program or portfolio company needs a buyer, a price, and a path to last.
Operators.
Universities and established companies and institutions.
When a program has proven itself and needs the partners and funding to grow.
Buyers.
Governments, multilaterals, and procurement agencies.
Ahead of pricing, supply, and partnership negotiations.
What we do
Where good work gains traction.
Good work rarely stalls on the idea. It stalls on the market, the money, the board, or the deal. We help you chart a path through, so the work reaches the people and places it was built for.
Why Avenir
Leaders call us for the gray-area problems, where science, markets, funding, and partnerships collide, the signals are mixed, and the stakes are high. We help turn promising ideas and relationships into decisions, deals, and coalitions.
Selected work
Capital strategy and investor preparation for a biotech company through a critical financing event
Market access and regulatory pathways for emerging infectious-disease biotech assets
Negotiation advisory with senior global health official on a leadership transition
Board search and governance advisory for a global health CEO
Peer-reviewed research on market shaping in global health, PLOS Global Public Health (2026)